Effects of rAAV-Mediated sox9 Overexpression on the Biological Activities of Human Osteoarthritic Articular Chondrocytes in Their Intrinsic Three-Dimensional Environment
Use este enlace para citar
http://hdl.handle.net/2183/37895
A non ser que se indique outra cousa, a licenza do ítem descríbese como Creative Commons Attribution (CC BY) license 4.0
Coleccións
Metadatos
Mostrar o rexistro completo do ítemTítulo
Effects of rAAV-Mediated sox9 Overexpression on the Biological Activities of Human Osteoarthritic Articular Chondrocytes in Their Intrinsic Three-Dimensional EnvironmentAutor(es)
Data
2019Cita bibliográfica
Daniels, O.; Frisch, J.; Venkatesan, J.K.; Rey-Rico, A.; Schmitt, G.; Cucchiarini, M. Effects of rAAV-Mediated sox9 Overexpression on the Biological Activities of Human Osteoarthritic Articular Chondrocytes in Their Intrinsic Three-Dimensional Environment. J. Clin. Med. 2019, 8, 1637. https://doi.org/10.3390/jcm8101637
Resumo
[Abstract] Gene therapy for osteoarthritis offers powerful, long-lasting tools that are well adapted to treat such a slow, progressive disorder, especially those therapies based on the clinically adapted recombinant adeno-associated viral (rAAV) vectors. Here, we examined the ability of an rAAV construct carrying a therapeutic sequence for the cartilage-specific SOX9 transcription factor to modulate the phenotype of human osteoarthritic articular chondrocytes compared with normal chondrocytes in a three-dimensional environment where the cells are embedded in their extracellular matrix. Successful sox9 overexpression via rAAV was noted for at least 21 days, leading to the significant production of major matrix components (proteoglycans, type-II collagen) without affecting the proliferation of the cells, while the cells contained premature hypertrophic processes relative to control conditions (reporter rAAV-lacZ application, absence of vector treatment). These findings show the value of using rAAV to adjust the osteoarthritic phenotype when the chondrocytes are confined in their inherently altered environment and the possibility of impacting key cellular processes via gene therapy to remodel human osteoarthritic cartilage lesions.
Palabras chave
Cartilage repair
Osteoarthritis
RAAV
SOX9
Chondrocyte phenotype
Osteoarthritis
RAAV
SOX9
Chondrocyte phenotype
Versión do editor
Dereitos
Creative Commons Attribution (CC BY) license 4.0